| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3061 |
| Trial ID | NCT05404048 |
| Disease | Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | atezolizumab |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Programmed Death Ligand 1 (PD-L1)-PET Imaging in Patients With (Diffuse) Large B-cell Lymphoma Who Are Treated With CD19-directed CAR T-cell Therapy: a Pilot Study |
| Year | 2022 |
| Country | Netherlands |
| Company sponsor | University Medical Center Groningen |
| Other ID(s) | 202100663 |
| Cohort 1 | |||||||
|
|||||||